Trypanosoma cruzi infection in North America and Spain: Evidence in support of transfusion transmission (CME)

Transfusion

Volumn 52, Issue 9, 2012, Pages 1913-1921

  Benjamin, Richard J ^a,b,c,d   Stramer, Susan L ^a,b,c,d   Leiby, David A ^a,b,c,d   Dodd, Roger Y ^a,b,c,d   Fearon, Margaret ^a,b,c,d   Castro, Emma ^a,b,c,d  

^a HOLLAND LABORATORY   (United States)

^b AMERICAN RED CROSS   (United States)

^c CANADIAN BLOOD SERVICES   (Canada)

^d American Red Cross Scientific Support Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

APHERESIS; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION TRANSMISSION; CANCER CHEMOTHERAPY; CHAGAS DISEASE; DISEASE TRANSMISSION; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOCOMPROMISED PATIENT; IRRADIATION; LEUKAPHERESIS; NORTH AMERICA; SPAIN; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW;

ANIMALS; BLOOD DONORS; BLOOD TRANSFUSION; CHAGAS DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; NORTH AMERICA; SPAIN; TRYPANOSOMA CRUZI;

EID: 84865758850     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03554.x     Document Type: Article

References (53)

1. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL,. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008; 21: 476-82.
2. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ,. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-55.
3. Lane DJ, Sher GD, Ward B, Ndao M, Leiby D, Hewlett B, Bow E,. Investigation of the second case of transfusion transmitted Chagas disease in Canada [abstract]. Blood 2000; 96 (Pt 1): 60a.
4. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT,. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341: 1237-9.
5. Perez de Pedro I, Martin Rico P, Santamaria S, Faez Y, Blanc P, Jesus Pascual M, Angeles Cuestra M, Munoz Perez MI, Carmen Villaita M, Vidales I, Heiniger AI,. Caso clinico de enfermedad de Chagas transfusional. Emf Emerg 2008; 10 (Suppl 1): 14-8.
6. Geiseler PJ, Ito JI, Tegtmeier BR, Kernt PR,. Fulminant Chagas disease (CD) in bone marrow transplantation (BMT). 27th ICAAC 1987;(Abstract 418): 169.
7. Abalo A, Adelantado M, Areal C, Castrillo A, Castro A, Cid J, Eiiras A, Flores J, Cabrera J,. Tracing of one year of Chagas screening at the Centro de Transfusion de Galicia (C.T.G.). Concerning a positive blood donor. Vox Sang 2007; 93: 140, Abstract P-235.
8. Kessler D, Grima KM, Hillyer CD,. Chagas transmission identified by lookback. Transfusion 2010; 50 (Suppl 1): Abstract 31A.
9. Ozaeto Orrono S, Rezola Llama AR, Ruiz Rodriguez M, Bejarano de Prado R, Ibarra Fontan A,. Enfermedad de Chagas Y donacion. XIX Congreso Nacional de la SETS 2008;Abstract S1-05.
10. Cimo PL, Luper WE, Scouros MA,. Transfusion-associated Chagas disease in Texas: report of a case. Tex Med 1993; 89: 48-50.
11. Grant IH, Gold JW, Wittner M, Tanowitz HB, Nathan C, Mayer K, Reich L, Wollner N, Steinherz L, Ghavimi F, O'Reilly RJ, Armstrong D,. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989; 111: 849-51.
12. Nickerson P, Orr P, Schroeder ML, Sekla L, Johnston JB,. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989; 111: 851-3.
13. Flores-Chavez M, Fernandez B, Puente S, Torres P, Rodríguez M, Monedero C, Cruz I, Gárate T, Cañavate C,. Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infect Dis 2008; 46: e44-7.
14. Villalba R, Fornes G, Alvarez MA, Román J, Rubio V, Fernández M, García JM, Viñals M, Torres A,. Acute Chagas disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis 1992; 14: 594-5.
15. Young C, Losikoff P, Chawla A, Glasser L, Forman E,. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007; 47: 540-4.
16. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, Paredes-Espinoza M, Ron-Guerrero CS, Delgado-Mejía M, Peña-Muñoz JG,. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006; 46: 298-304.
17. Schmunis GA,. Prevention of transfusional Trypanosoma cruzi infection in Latin America. Mem Inst Oswaldo Cruz 1999; 94 (Suppl 1): 93-101.
18. Stramer SL, Townsend RL, Foster GA, Krysztof DE, Noedel P, Caglioti SG, Nguyen I, Procter C, Leiby DA,. U.S. blood donor screening for Typanosoma cruzi: clinical studies and first year experience. Vox Sang 2008; 95 (Suppl 1): 74-326.
19. FDA. Food and Drug Administration Blood Product Advisory Committee. April 1-2, 2009. [cited 2012 Jan 23]. Available from: URL: http://www.fda.gov/ AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/ BloodProductsAdvisoryCommittee/ucm121612.htm
20. Stramer SL, Foster G, Townsend R, Krysztof D, Notari EP IV, Trouern-Trend J, Bodsky J, Lenes B, Nguyen M, Bet A, Leiby D, Roualt C, Dodd R,. Trypanosoma cruzi antibody screening in US blood donors: one year experience at the American Red Cross. Transfusion 2008; 48 (Suppl 2S): 2a. Abstract P5-020A.
21. Stramer SL, Notari EP IV, Townsend RL, Custer B, Kamel H, Busch MP, Dodd RY,. No evidence of Trypanosoma cruzi incidence in US blood donors: a 4-year study. Transfusion 2011; 51 (Suppl 3S): 1A. Abstract P1-020A.
22. Castro E,. Chagas' disease: lessons from routine donation testing. Transfus Med 2009; 19: 16-23.
23. O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi QL, Goldman M, Scalia V, Fearon MA,. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing. Transfusion 2008; 48: 755-61.
24. FDA. Food and Drug Administration Blood Products Advisory Committee. August 2-3, 2011. [cited 2012 Jan 23]. Available from: URL: http://www.fda.gov/ AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/ BloodProductsAdvisoryCommittee/ucm247665.htm
25. CDC. National Healthcare Safety Network imputability criteria. 2011. [cited 2011 Jan 21]. Available from: URL: http://www.cdc.gov/nhsn/PDFs/ Biovigilance/BV-Protocol-1-3-1-June-2011.pdf
26. Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO,; GeoSentinel Surveillance Network. Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience. Clin Infect Dis 2011; 53: 523-31.
27. Dean AG, Sullivan KM, Soe MM,. OpenEpi: open source epidemiologic statistics for public health, version 2.3.1. 2008.
28. Stramer L, Townsend L, Foster A, Krysztof E, Leiby DA, Brodsky P, Roualt Ch, Lenes A, Dodd RY,. Experience with selective testing for antibodiy to Trypanosoma cruzi following validation using universal testing. Vox Sang 2010; 99 (Suppl 1): 313-4.
29. Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY,. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis 1997; 176: 1047-52.
30. Leiby DA, Fucci MH, Stumpf RJ,. Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission. Transfusion 1999; 39: 310-5.
31. Kerndt PR, Waskin HA, Kirchhoff LV, Steurer F, Waterman SH, Nelson JM, Gellert GA, Shulman IA,. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991; 31: 814-8.
32. Fearon M, Scalia V, Dines IR, Huang M, Hawes G, Ndao M,. Chagas selective testing screening. Transfusion 2011; 51 (Suppl 1): 29A. Abstract S63-030F.
33. Centers for Disease Control and Prevention (CDC). Blood donor screening for Chagas disease-United States, 2006-2007. Morb Mortal Wkly Rep 2007; 56: 141-3.
34. Schmunis GA, Yadon ZE,. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010; 115: 14-21.
35. Ministry of Health. Real Cedreto 1088/2005 por el que se establecen los requisitos tecnicos y condiciones minimas de la hemodonacion y de los centros y servicios de transfusion del 20 de septiembre de 2005. Boletin Oficial del Estado 2005; 225: 31288-304.
36. Whitaker BI, Green J, King MR, Leiberg LL, Mathew SM, Schlumpf KS, Schreiber GB,. The 2007 national blood collection and utilization survey. 2008. [cited 2010 Oct 9]. Available from: URL: http://www.hhs.gov/ophs/bloodsafety/ 2007nbcus-survey.pdf
37. American Association of Blood Banks. AABB Chagas' disease biovigilance network. 2011. [cited 2011 Aug 26]. Available from: URL: http://wwwaabborg/ programs/biovigilance/Pages/chagasaspx
38. Schmunis GA,. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991; 31: 547-57.
39. Galaviz-Silva L, Molina-Garza DP, Gonzalez-Santos MA, Mercado-Hernández R, González-Galavíz JR, Rosales-Encina JL, Molina-Garza ZJ,. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. Am J Trop Med Hyg 2009; 81: 404-6.
40. Ramos-Ligonio A, Ramirez-Sanchez ME, Gonzalez-Hernandez JC, Rosales-Encina JL, Lopez-Monteon A,. [Prevalence of antibodies against Trypanosoma cruzi in blood bank donors from the IMSS General Hospital in Orizaba, Veracruz, Mexico]. Salud Publica Mex 2006; 48: 13-21.
41. Hernandez-Becerril N, Mejia AM, Ballinas-Verdugo MA, Garza-Murillo V, Manilla-Toquero E, Lõpez R, Trevethan S, Cardenas M, Reyes PA, Hirayama K, Monteõn VM,. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 2005; 100: 111-6.
42. Sanchez-Guillen MC, Barnabe C, Guegan JF, Tibayrenc M, Velásquez-Rojas M, Martínez-Munguía J, Salgado-Rosas H, Torres-Rasgado E, Rosas-Ramírez MI, Pérez-Fuentes R,. High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. Mem Inst Oswaldo Cruz 2002; 97: 947-52.
43. Monteon-Padilla VM, Hernandez-Becerril N, Guzman-Bracho C, Rosales-Encina JL, Reyes-Lopez PA,. American trypanosomiasis (Chagas' disease) and blood banking in Mexico City: seroprevalence and its potential transfusional transmission risk. Arch Med Res 1999; 30: 393-8.
44. Trujillo Contreras F, Lozano Kasten F, Soto Gutierrez MM, Hernandez Gutierrez R,. [The prevalence of Trypanosoma cruzi infection in blood donors in the state of Jalisco, Mexico]. Rev Soc Bras Med Trop 1993; 26: 89-92.
45. Wendel S,. Chagas disease: an old entity in new places. Int J Artif Organs 1993; 16: 117-9.
46. Leiby DA, Rentas FJ, Nelson KE, Stambolis VA, Ness PM, Parnis C, McAllister HA Jr, Yawn DH, Stumpf RJ, Kirchhoff LV,. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. Circulation 2000; 102: 2978-82.
47. Atias A, Lorca M, Canales M, Mercado R, Reyes V, Child R,. Chagas disease: transmission by blood transfusion in Chile (Spanish). Bol Hosp San Jaun De Dios (Santiago) 1984; 31: 301-6.
48. Lorca M, Lorca E, Atias A, Plubins L,. [Chagas disease in patients in chronic hemodialysis. Prevalence and risk of transmission by blood transfusion]. Rev Med Chil 1989; 116: 509-13.
49. Girones N, Bueno JL, Carrion J, Fresno M, Castro E,. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma. Vox Sang 2006; 91: 285-91.
50. Dzib D, Hernandez VP, Ake BC, Lopez RA, Monteon VM,. Leukoreduction by centrifugation does not eliminate Trypanosoma cruzi from infected blood units. Vector Borne Zoonotic Dis 2009; 9: 235-41.
51. Moraes-Souza H, Bordin JO, Bardossy L, MacPherson DW, Blajchman MA,. Prevention of transfusion-associated Chagas disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Transfusion 1995; 35: 723-6.
52. Leiby DA, Nguyen L, Procter C, Townsend L, Stramer SL,. Impact of Trypanosoma cruzi phylogenetic lineage on transfusion transmission in the United States [abstract]. Vox Sang 2011; 99 (Suppl 1): 64.
53. Custer B, Agapova M, Biswas HH, Busch MP, Tomasulo P, Kamel H,. Do pre-donation questions identify donors at higher risk for Trypanosoma cruzi infection ? Transfusion 2009; 49 (Suppl 1): 17A. Abstract S37-020D.